课题基金 / 基金详情

项目摘要

项目成果

SHIV Subramaniam PILLAI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):记忆细胞难以在人类受试者中进行功能定义。已经接受人胸腺和胎肝植入物的人源化小鼠产生人免疫系统,并自发地响应内源性和环境抗原,以产生具有假定IgM记忆/活化B细胞和类别转换记忆/活化B细胞表型的细胞。我们将使用免疫和BrdU标记策略来鉴定在延长的时间内保留BrdU标记的抗原特异性B细胞,以便在功能上定义人IgM记忆和类别转换记忆细胞。关于人IgM+ CD 27 + B细胞起源的争议也可能在人源化小鼠的类似研究中得到解决。 公共卫生相关性:定义和理解人类记忆B细胞的起源将有助于开发新的和合理的疫苗生产方法。这些细胞也与许多人类B谱系恶性肿瘤有关,从淋巴瘤发生的角度来看,了解这些自然长寿的B细胞的生物学将是重要的。
英文摘要
DESCRIPTION (provided by applicant): Memory cells are difficult to functionally define in human subjects. Humanized mice that have received implants of human thymus and fetal liver generate a human immune system and spontaneously respond to endogenous and environmental antigens to generate cells with the phenotype of presumed IgM memory/activated B cells and class-switched memory/activated B cells. We will use an immunization and BrdU labeling strategy to identify antigen-specific B cells that retain BrdU label over extended periods in order to functionally define human IgM memory and class-switched memory cells. Controversies regarding the origins of human IgM+CD27+ B cells may also be resolved in similar studies on humanized mice. PUBLIC HEALTH RELEVANCE: Relevance Defining and understanding the origins of human memory B cells will help the development of novel and rational approaches for vaccine generation. These cells are also linked to a number of human B lineage malignancies and understanding the biology of these naturally long-lived B cells will be of importance from a lymphomagenesis standpoint.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Immunological Tolerance and Autoimmunity
  • 批准号:
    9102896
  • 项目类别:
  • 资助金额:
    $18.74万
  • 财政年份:
    2015
  • 负责人:
    SHIV Subramaniam PILLAI
  • 依托单位:
Training Program in Immunological Tolerance and Autoimmunity
  • 批准号:
    9264976
  • 项目类别:
  • 资助金额:
    $18.95万
  • 财政年份:
    2015
  • 负责人:
    SHIV Subramaniam PILLAI
  • 依托单位:
Training Program in Immunological Tolerance and Autoimmunity
  • 批准号:
    8933644
  • 项目类别:
  • 资助金额:
    $18.55万
  • 财政年份:
    2015
  • 负责人:
    SHIV Subramaniam PILLAI
  • 依托单位:
An Autoimmune center of excellence for the study of IgG4-related disease
  • 批准号:
    8680709
  • 项目类别:
  • 资助金额:
    $71.29万
  • 财政年份:
    2014
  • 负责人:
    SHIV Subramaniam PILLAI
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究